Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients

NCT01374165 · clinicaltrials.gov ↗
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Study cancelled.

Conditions

Sponsor

Prolong Pharmaceuticals